Frailty in elderly COPD patients a cross-sectional study
Keywords:
pulmonary disease, chronic obstructive, chronic disease, frailty, frail elderly, disease exacerbation, physiological phenomena, hospitalization, pulmonary function tests, public healthMain Article Content
Objective
This study aimed to determine frailty prevalence among patients aged ≥65 diagnosed with Chronic Obstructive Pulmonary Disease (COPD) and investigate its relationship with disease severity, hospitalization rates, and acute exacerbation frequency.
Methods
This cross-sectional study evaluated 112 elderly patients with COPD. Patient records, pulmonary function tests, Modified Medical Research Council (mMRC) dyspnea scores, COPD Assessment Test (CAT) scores, and the previous year's exacerbations and hospitalizations were analyzed. Frailty was assessed using the FRAIL scale.
Results
Frailty prevalence was 49.1% (55/112). A significant negative correlation was found between FRAIL and FEV1% values (rs: -0.695, 95% CI: -0.782 to -0.581, p <0.001). Conversely, FRAIL scores correlated positively with CAT (rs: 0.840, 95% CI: 0.773 to 0.888, p <0.001) and mMRC values (rs: 0.733, 95% CI: 0.631 to 0.811, p <0.001). Significant differences in CAT, mMRC, and FEV1% were observed between high and low frailty groups. COPD exacerbations and hospitalizations were significantly higher in patients with higher FRAIL scores (p <0.001).
Conclusion
The FRAIL scale is strongly associated with higher rates of exacerbations and hospitalizations in elderly COPD patients, reflecting increased disease severity and poorer clinical outcomes.
1. Ozdemir T, Kilic H, Demirci NY, Ozdilekcan C, Bektemur G, Turkkani MH, et al. Five-Year Trends in Direct Costs of Chronic Obstructive Pulmonary Disease in Turkey: COPDTURKEY-3. Turk Thorac J. 2021;22(5):393-398. https://doi.org/10.5152/TurkThoracJ.2021.19150. PMid:35110213; PMCid:PMC8975325.
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis and management of COPD: 2024 report. Illinois: GOLD; 2024 [cited 2024 March]. Available from: https://goldcopd.org/2024-gold-report/
3. Scioscia G, Blanco I, Arismendi E, Burgos F, Gistau C, Foschino-Barbaro MP, et al. Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations. Thorax. 2017;72(2):117-21. https://doi.org/10.1136/thoraxjnl-2016-208332. PMid:27586869
4. Lo Buglio A, Scioscia G, Bellanti F, Tondo P, Soccio P, Natale MP, et al. Controlling nutritional status score as a predictor for chronic obstructive pulmonary disease exacerbation risk in elderly patients. Metabolites. 2023;13(11):1123. https://doi.org/10.3390/metabo13111123. PMid:37999219; PMCid:PMC10673254
5. Dent E, Martin FC, Bergman H, Woo J, Romero-Ortuno R, Walston JD. Management of frailty: opportunities, challenges, and future directions. Lancet. 2019;394(10206):1376-86. https://doi.org/10.1016/S0140-6736(19)31785-4. PMid:31609229
6. Roche N, Zureik M, Soussan D, Neukirch F, Perrotin D, the Urgence BPCO (COPD Emergency) Scientific Committee and investigators. Predictors of outcomes in COPD exacerbation cases presenting to the emergency department. Eur Respir J. 2008;32(4):953-61. https://doi.org/10.1183/09031936.00129507. PMid:18508819
7. Morley JE. Anorexia, sarcopenia, and aging. Nutrition. 2001;17(7-8):660-3. https://doi.org/10.1016/S0899-9007(01)00574-3. PMid:11448592
8. Dias LS, Ferreira ACG, da Silva Junior JLR, Conte MB, Rabahi MF. Prevalence of frailty and evaluation of associated variables among COPD patients. Int J Chron Obstruct Pulmon Dis. 2020;15:1349-1356. https://doi.org/10.2147/COPD.S250299. PMid:32606644; PMCid:PMC7297564
9. Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet. 2019;394(10206):1365-75. https://doi.org/10.1016/S0140-6736(19)31786-6. PMid:31609228
10. Galizia G, Cacciatore F, Testa G, Della-Morte D, Mazzella F, Langellotto A, et al. Role of clinical frailty on long-term mortality of elderly subjects with and without chronic obstructive pulmonary disease. Aging Clin Exp Res. 2011;23(2):118-25. https://doi.org/10.1007/BF03351076. PMid:21743290
11. Marengoni A, Vetrano DL, Manes-Gravina E, Bernabei R, Onder G, Palmer K. The relationship between COPD and frailty. Chest. 2018;154(1):21-40. https://doi.org/10.1016/j.chest.2018.02.014. PMid:29477493
12. Lahousse L, Ziere G, Verlinden VJA, Zillikens MC, Uitterlinden AG, Rivadeneira F, et al. Risk of frailty in elderly with COPD: a population-based study. J Gerontol A Biol Sci Med Sci. 2016;71(5):689-95. https://doi.org/10.1093/gerona/glv154. PMid:26355016
13. Maddocks M, Kon SSC, Canavan JL, Jones SE, Nolan CM, Labey A, et al. Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study. Thorax. 2016;71(11):988-95. https://doi.org/10.1136/thoraxjnl-2016-208460. PMid:27293209; PMCid:PMC5099190
14. Kennedy CC, Novotny PJ, LeBrasseur NK, Wise RA, Sciurba FC, Benzo RP. Frailty and clinical outcomes in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2019;16(2):217-224. https://doi.org/10.1513/AnnalsATS.201803-175OC. PMid:30433830; PMCid:PMC6376949
15. Sternberg SA, Schwartz AW, Karunananthan S, Bergman H, Clarfield MA. The ıdentification of frailty: a systematic literature review. J Am Geriatr Soc. 2011;59(11):2129-38. https://doi.org/10.1111/j.1532-5415.2011.03597.x. PMid:22091630
16. Ofori-Asenso R, Chin KL, Mazidi M, Zomer E, Ilomaki J, Zullo AR, et al. Global ıncidence of frailty and prefrailty among community-dwelling older adults: a systematic review and meta-analysis. JAMA Netw Open. 2019;2(8):e198398. https://doi.org/10.1001/jamanetworkopen.2019.8398. PMid:31373653; PMCid:PMC6681553
17. Hymabaccus BAB, Dogrul RT, Balci C, Ozsurekci C, Caliskan H, Karabulut E, et al. An effective and practical tool to assess physical frailty in older adults: Turkish validation of the FRAIL Scale. Marmara Med J. 2023;36(2):149-56. https://doi.org/10.5472/marumj.1297696
18. Wang L, Zhang X, Liu X. Prevalence and clinical impact of frailty in COPD: a systematic review and meta-analysis. BMC Pulm Med. 2023;23(1):164. https://doi.org/10.1186/s12890-023-02454-z. PMid:37173728; PMCid:PMC10182679
19. Ierodiakonou D, Kampouraki M, Poulonirakis I, Papadokostakis P, Lintovoi E, Karanassos D, et al. Determinants of frailty in primary care patients with COPD: the Greek UNLOCK study. BMC Pulm Med. 2019;19(1):63. https://doi.org/10.1186/s12890-019-0824-8. PMid:30876423; PMCid:PMC6419845
20. Park SK, Richardson CR, Holleman RG, Larson JL. Frailty in people with COPD, using the National Health and Nutrition Evaluation Survey dataset (2003–2006). Heart Lung. 2013;42(3):163-70. https://doi.org/10.1016/j.hrtlng.2012.07.004. PMid:23535142; PMCid:PMC4020241
21. Naval E, González MC, Giraldós S, Calatayud J, Jornet M, Lluch I, et al. Frailty assessment in a stable COPD cohort: ıs there a COPD-Frail Phenotype? COPD. 2021;18(5):525-32. https://doi.org/10.1080/15412555.2021.1975670. PMid:34503389
22. Yee N, Locke ER, Pike KC, Chen Z, Lee J, Huang JC, et al. Frailty in chronic obstructive pulmonary disease and risk of exacerbations and hospitalizations. Int J Chron Obstruct Pulmon Dis. 2020;15:1967-76. https://doi.org/10.2147/COPD.S245505. PMid:32848382; PMCid:PMC7429100
23. Limpawattana P, Putraveephong S, Inthasuwan P, Boonsawat W, Theerakulpisut D, Chindaprasirt J. Frailty syndrome in ambulatory patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:1193-8. https://doi.org/10.2147/COPD.S134233. PMid:28458530; PMCid:PMC5402886
24. Kusunose M, Oga T, Nakamura S, Hasegawa Y, Nishimura K. Frailty and patient-reported outcomes in subjects with chronic obstructive pulmonary disease: are they independent entities? BMJ Open Respir Res. 2017;4(1):e000196. https://doi.org/10.1136/bmjresp-2017-000196. PMid:28883929; PMCid:PMC5531303
25. Scarlata S, Finamore P, Laudisio A, Cardaci V, Ramaccia M, D’Alessandro F, et al. Association between frailty index, lung function, and major clinical determinants in chronic obstructive pulmonary disease. Aging Clin Exp Res. 2021;33(8):2165-73. https://doi.org/10.1007/s40520-021-01878-z. PMid:34009526
Downloads

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use
